Network Modeling of the Dasatinib Treatment in Glioblastoma Stem Cells by Data Integration

Date

2017-06-28

Author

Senger, Gokce
Tunçbağ, Nurcan

Metadata

Show full item record

Item Usage Stats

171
views

0
downloads

URI

http://hibit2017.ii.metu.edu.tr/wordpress/wp-content/uploads/HIBIT2017_Conference_Book.pdf
https://hdl.handle.net/11511/76025

Collections

Unverified, Conference / Seminar

Suggestions

OpenMETU
Core

Network models for understanding boron-induced transcriptomics changes within HepG2 cell line Tombuloğlu, Ayşegül; Çöpoğlu, Hülya; Güray, Nülüfer Tülün; Son Aydın, Yeşim (null; 2018-10-25) Boron has crucial roles in plant growth and survival; also, it is suggested as an essential trace element forhuman physiology. Accumulating evidence show beneficial effects of boron for human health. Along withits benefits to bone and brain health, many findings support the anti-carcinogenic role of dietary boron.Although biochemical significance of boron is evident, relatively few studies focus on boron-inducedbiological processes and mechanisms at the molecular level.In this work, we aim to reveal the bor...
Network Modeling Identifies Patient-specific Pathways in Glioblastoma. Tunçbağ, Nurcan; POKORNY, JL; JOHNSON, H; SIO, TT; DALIN, S; IYEKEGBE, DO; WHITE, FM; SARKARIA, JN; FRAENKEL, E (2016-06-29) Glioblastoma is the most aggressive type of malignant human brain tumor. Molecular profiling experiments have revealed that these tumors are extremely heterogeneous. This heterogeneity is one of the principal challenges for developing targeted therapies. We hypothesize that despite the diverse molecular profiles, it might still be possible to identify common signaling changes that could be targeted in some or all tumors. Using a network modeling approach, we reconstruct the altered signaling pathways from t...
Network-based in silico modeling for drug repurposing and in vitro validation in hepatocellular carcinoma Nalbat, Esra; Tunçbağ, Nurcan; Cetin-Atalay, Rengul (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10) Hepatocellular carcinoma (HCC) is the sixth most commonly diagnosed cancer and a leading cause of death worldwide. The hyperactivated cell survival signaling pathways cause resistance to conventional chemotherapeutics so that targeted therapies could extend patient survival for only a few months. Furthermore, there are limited chemotherapeutics for HCC patients due to impaired liver functions. Thus, it is vital to determine repurposed drugs and drug combinations in HCC treatment.
Network structure based pathway enrichment system to analyze pathway activities Işık, Zerrin; Atalay, Mehmet Volkan; Atalay, Rengül; Department of Computer Engineering (2011) Current approaches integrating large scale data and information from a variety of sources to reveal molecular basis of cellular events do not adequately benefit from pathway information. Here, we portray a network structure based pathway enrichment system that fuses and exploits model and data: signalling pathways are taken as the biological models while microarray and ChIP-seq data are the sample input data sources among many other alternatives. Our model- and data-driven hybrid system allows to quantitati...
Network-based discovery of molecular targeted agent treatments in hepatocellular carcinoma Fayetörbay, Rumeys; Tunçbağ, Nurcan; Department of Bioinformatics (2020) Hepatocellular carcinoma (HCC) is one of the most-deadly cancers and the most common type of primary liver cancer. Multikinase inhibitor Sorafenib is one of FDA approved targeted agents in HCC treatment. PI3K/AKT/mTOR pathway is altered in about 51% of HCC; hence, understanding how Sorafenib and PI3K/AKT/mTOR pathway inhibitors act at signaling level is crucial for targeted therapies and to reveal the off-target effects. In this work, we use gene expression profiles (GEPs) of HCC cells (Huh7 and Mahlavu) wh...

Citation Formats

G. Senger and N. Tunçbağ, “Network Modeling of the Dasatinib Treatment in Glioblastoma Stem Cells by Data Integration,” 2017, Accessed: 00, 2021. [Online]. Available: http://hibit2017.ii.metu.edu.tr/wordpress/wp-content/uploads/HIBIT2017_Conference_Book.pdf.